UBS AM’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
227,741
+129,107
| +131% | +$1.19M | ﹤0.01% | 2115 |
|
|
2025
Q1 | $846K | Buy |
+98,634
| New | +$846K | ﹤0.01% | 2373 |
|
|
2024
Q2 | – | Sell |
-96,924
| Closed | -$493K | – | 2807 |
|
|
2024
Q1 | $493K | Hold |
96,924
| – | – | ﹤0.01% | 2289 |
|
|
2023
Q4 | $902K | Hold |
96,924
| – | – | ﹤0.01% | 2087 |
|
|
2023
Q3 | $635K | Hold |
96,924
| – | – | ﹤0.01% | 2186 |
|
|
2023
Q2 | $831K | Hold |
96,924
| – | – | ﹤0.01% | 2087 |
|
|
2023
Q1 | $831K | Buy |
+96,924
| New | +$831K | ﹤0.01% | 2087 |
|
|
2022
Q4 | – | Sell |
-96,244
| Closed | -$993K | – | 2580 |
|
|
2022
Q3 | $993K | Hold |
96,244
| – | – | ﹤0.01% | 1975 |
|
|
2022
Q2 | $963K | Buy |
96,244
+31,859
| +49% | +$319K | ﹤0.01% | 1987 |
|
|
2022
Q1 | $793K | Hold |
64,385
| – | – | ﹤0.01% | 2260 |
|
|
2021
Q4 | $1.12M | Sell |
64,385
-4,366
| -6% | -$75.7K | ﹤0.01% | 2154 |
|
|
2021
Q3 | $1.23M | Buy |
68,751
+567
| +0.8% | +$10.2K | ﹤0.01% | 2051 |
|
|
2021
Q2 | $1.56M | Buy |
+68,184
| New | +$1.56M | ﹤0.01% | 1970 |
|